Immunohistochemical characterization of immune cell infiltrate in gastrointestinal stromal tumor and its prognostic correlation

2020 ◽  
Vol 40 (2) ◽  
pp. 229
Author(s):  
Reham S. ElNemr Esmail ◽  
YousryW Nada ◽  
Amr Kamal ◽  
Hussein ElSayed ◽  
NohaM El-Anwer
Hematology ◽  
2017 ◽  
Vol 2017 (1) ◽  
pp. 310-316 ◽  
Author(s):  
W. Robert Liu ◽  
Margaret A. Shipp

Abstract Classical Hodgkin lymphoma (cHL) is an unusual B-cell–derived malignancy in which rare malignant Hodgkin and Reed-Sternberg (HRS) cells are surrounded by an extensive but ineffective inflammatory/immune cell infiltrate. This striking feature suggests that malignant HRS cells escape immunosurveillance and interact with immune cells in the cancer microenvironment for survival and growth. We previously found that cHLs have a genetic basis for immune evasion: near-uniform copy number alterations of chromosome 9p24.1 and the associated PD-1 ligand loci, CD274/PD-L1 and PDCD1LG2/PD-L2, and copy number–dependent increased expression of these ligands. HRS cells expressing PD-1 ligands are thought to engage PD-1 receptor–positive immune effectors in the tumor microenvironment and induce PD-1 signaling and associated immune evasion. The genetic bases of enhanced PD-1 signaling in cHL make these tumors uniquely sensitive to PD-1 blockade.


2020 ◽  
Vol 10 ◽  
Author(s):  
Kasia A. Sablik ◽  
Ekaterina S. Jordanova ◽  
Noelle Pocorni ◽  
Marian C. Clahsen-van Groningen ◽  
Michiel G. H. Betjes

2002 ◽  
Vol 82 (5) ◽  
pp. 663-665 ◽  
Author(s):  
Takahiro Taguchi ◽  
Hiroshi Sonobe ◽  
Shin-ichi Toyonaga ◽  
Ichiro Yamasaki ◽  
Taro Shuin ◽  
...  

Blood ◽  
2017 ◽  
Vol 130 (21) ◽  
pp. 2265-2270 ◽  
Author(s):  
W. Robert Liu ◽  
Margaret A. Shipp

Abstract Classical Hodgkin lymphoma (cHL) is an unusual B-cell–derived malignancy in which rare malignant Hodgkin and Reed-Sternberg (HRS) cells are surrounded by an extensive but ineffective inflammatory/immune cell infiltrate. This striking feature suggests that malignant HRS cells escape immunosurveillance and interact with immune cells in the cancer microenvironment for survival and growth. We previously found that cHLs have a genetic basis for immune evasion: near-uniform copy number alterations of chromosome 9p24.1 and the associated PD-1 ligand loci, CD274/PD-L1 and PDCD1LG2/PD-L2, and copy number–dependent increased expression of these ligands. HRS cells expressing PD-1 ligands are thought to engage PD-1 receptor–positive immune effectors in the tumor microenvironment and induce PD-1 signaling and associated immune evasion. The genetic bases of enhanced PD-1 signaling in cHL make these tumors uniquely sensitive to PD-1 blockade.


2018 ◽  
Vol 20 (suppl_2) ◽  
pp. i74-i75
Author(s):  
Timothy A Ritzmann ◽  
Francesca Francis ◽  
Sarah-Louise Brudenell ◽  
Hazel A Rogers ◽  
Alex Virasami ◽  
...  

2013 ◽  
Vol 15 (11) ◽  
pp. 1479-1490 ◽  
Author(s):  
L. Fang ◽  
D. E. Lowther ◽  
M. L. Meizlish ◽  
R. C. E. Anderson ◽  
J. N. Bruce ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document